Abstract:Objective To study the relationship between mutation of epidermal growth factor receptor(EGFR) gene of patients with non―small cell lung cancer(NSCLC) and origin of sample, and discuss the feasibility and reliability of tissue sample, blood sample and malignant pleural effusion sample in detection of EGFR gene mutation. Methods From July 1, 2013 to July 1, 2016, a total of 157 tissue samples, 23 blood samples and 20 malignant pleural effusion samples of NSCLCpatients from De-partment of Thoracic Surgery, Oncology and General Surgery in First Affiliated Hospital of Jinzhou Medical University were collected. The patients included 127 males and 73 females, aged 35―82 years old with mean age of 61 years old, 67 cases≤61―year―old and 133 cases > 61―year―old. The E.Z.N.A.TM Tissue DNA Kit (OMEGA company) was used to extract DNA of tissue sample, the Human EGFR Gene Mutation Fluorescence Polymerase Chain Reaction(PCR) Diagnostic Kit was used to extract the DNA of blood sample and malignant pleural effusion sample, and fluorescent quantitation RCR was used to detect the EGFR. Results The EGFR gene mutation rate of tissue samples was 42.7 %(67/157), blood samples was 34.8 % and leural effusion sample was 80.0%(16/20). The EGFR gene mutation rates of tissue samples were different in different gender(χ2=1.837, P=0.274), different age(χ2= 0.645, P = 0.247) and TNM staging(χ2= 1.645, P = 0.427), and there was no significant differ-ence between the groups . The differences in smoking and non―smoking patients were statistically significant (χ2 = 2 . 674 , P=0.036). There was no significant difference in EGFR gene mutation rates between gross and punctured samples(χ2=2.165, P = 0.374). The EGFR gene mutation rate of metastatic was higher than that of primary tumor, and the difference was statisti-cally significant(χ2=4.148, P=0.043). The EGFR gene mutation rate of adenocarcinoma was higher than that of non―adenocar-cinoma, and the difference was statistically significant(χ2=5.274, P=0.021). Conclusion The patients with adenocarcinoma showed high incidence rate of EGFR gene mutation in NSCLC patients, which is unrelated to gender, age, TNM staging, smok-ing and physical state;the EGFR mutation rate of metastatic focus is higher than that of primary focus, the patients with pleu-ral effusion have a higher EGFR mutation rate than those without pleural effusion, the patients with adenocarcinoma have higher EGFR gene mutation rate than those without adenocarcinoma. Due to the tumor heterogeneity, tumor tissues from differ-ent positions(primary and metastatic) and parts should be obtained for detection as early as possible, otherwise EGFR genetic mutation of blood sample and pleural effusion sample should be detected.

Comparison of Multi-Gene Testing Data Between Fresh and Formalin-Fixed Specimens From Core Needle Biopsy in Patients With NSCLC

Clinical significance of multi-sample next-generation sequencing for detection of gene mutations in non-small cell lung cancer

Comparison of Fresh Frozen Tissue With Formalin-Fixed Paraffin-Embedded Tissue for Mutation Analysis Using a Multi-Gene Panel in Patients With Colorectal Cancer

Comparative Analysis of the Representative Value of Somatic Mutation Profiles Derived from Ctdna and Other Updated Lung Tumor Biopsy Alternative in Non-Resectable Non-Small Cell Lung Cancer Patients.

Performance Study of an Amplification-Based NGS Test on Clinical FFPE Specimens in China's First Multi-Center Study.

Detection of EGFR Gene Mutation Status from Pleural Effusions and Other Body Fluid Specimens in Patients with Lung Adenocarcinoma

A Prospective Comparison Study on EGFR Mutations by Direct Sequencing and ARMS in Completely Resected Chinese Non-Small Cell Lung Cancer with Adenocarcinoma Histology (ICAN).

Multigene PCR Using Both Cfdna and Cfrna in the Supernatant of Pleural Effusion Achieves Accurate and Rapid Detection of Mutations and Fusions of Driver Genes in Patients with Advanced NSCLC

Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing

Abstract 558: Muti-gene ARMS PCR Using Both Cfdna and Cfrnain the Supernatant of Pleural Effusion Achieves Rapid and Accuracy Driver Gene Mutations Detection

P1.03-07 A Comparison of Consistency of Detecting HER2 Gene Mutations in Peripheral Blood and Tumor Tissue of Non-Small-Cell Lung Cancer Patients

Methodological and TNM Focus-Based Comparison of EGFR Mutation Status in Non-Small-Cell Lung Carcinomas

Mutation of epidermal growth factor receptor gene in non-small cell lung cancer patients with different biological samples and clinical pathophysiological characteristics

Gene Mutation Analysis in Non-Small Cell Lung Cancer Patients using Bronchoalveolar Lavage Fluid and Tumor Tissue as Diagnostic Markers

Comprehensive Analysis of NGS and ARMS-PCR for Detecting EGFR Mutations Based on 4467 Cases of NSCLC Patients

Comparison of the Somatic Mutations Between Circulating Tumor DNA and Tissue DNA in Chinese Patients with Non-Small Cell Lung Cancer.

Evaluation of Liquid Based Cytology in Detection of EGFR Mutation in NSCLC by Large Samples

EGFR Gene Mutation and Methodological Evaluation in 399 Patients with Non-small Cell Lung Cancer

Comparison of Next-Generation Sequencing and Immunohistochemistry Analysis for Targeted Therapy-Related Genomic Status in Lung Cancer Patients.

Next-Generation Sequencing for Genotyping of Endobronchial Ultrasound- Guided Transbronchial Needle Aspiration Samples in Lung Cancer

Comparative study on the mutation spectrum of tissue DNA and blood ctDNA in patients with non-small cell lung cancer